Iguana Healthcare Management’s Regenxbio RGNX Stock Holding History

Iguana Healthcare Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-30,000	Closed	-$998K	–	69
2017 Q4	$998K	Buy	+30,000	New	+$904K	0.65%	47

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Iguana Healthcare Management's RGNX Position: Q1 2018 in Review

Iguana Healthcare Management sold out of Regenxbio (RGNX) in Q1 2018, closing a stake of 30,000 shares — an estimated $998K sold.

Iguana Healthcare Management first reported a position in RGNX in Q4 2017 and held it in 1 quarter. The position peaked at $998K in Q4 2017. 120 funds tracked by Wall St. Rank hold RGNX as of Q1 2018.

Iguana Healthcare Management reported no remaining Regenxbio position as of Q1 2018 after selling out during the quarter.
Iguana Healthcare Management sold 30,000 Regenxbio shares in Q1 2018, an estimated $998K.
Iguana Healthcare Management first reported a position in Regenxbio in Q4 2017 and held it in 1 quarter.
Iguana Healthcare Management's Regenxbio position peaked at $998K in Q4 2017.
120 funds tracked by Wall St. Rank held Regenxbio as of Q1 2018.

Based on Iguana Healthcare Management's 13F filing for Q1 2018, filed 15 May 2018.